Mutaib M. Mashraqi

513 total citations
36 papers, 364 citations indexed

About

Mutaib M. Mashraqi is a scholar working on Molecular Biology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Mutaib M. Mashraqi has authored 36 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 9 papers in Infectious Diseases. Recurrent topics in Mutaib M. Mashraqi's work include Computational Drug Discovery Methods (10 papers), vaccines and immunoinformatics approaches (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Mutaib M. Mashraqi is often cited by papers focused on Computational Drug Discovery Methods (10 papers), vaccines and immunoinformatics approaches (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Mutaib M. Mashraqi collaborates with scholars based in Saudi Arabia, Pakistan and India. Mutaib M. Mashraqi's co-authors include Ahmad Alzamami, Saleh Alshamrani, Youssef Saeed Alghamdi, Shaban Ahmad, Norah A. Alturki, Afaf Alharthi, Fahad A. Alhumaydhi, Zarrin Basharat, Usman Ali Ashfaq and Mohsin Khurshid and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and Current Medicinal Chemistry.

In The Last Decade

Mutaib M. Mashraqi

34 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mutaib M. Mashraqi Saudi Arabia	12	184	90	80	67	41	36	364
Hafiz Muzzammel Rehman Pakistan	13	198 1.1×	106 1.2×	111 1.4×	49 0.7×	37 0.9×	62	480
Jae-June Dong South Korea	13	183 1.0×	95 1.1×	48 0.6×	106 1.6×	39 1.0×	27	422
Asma Abro Pakistan	11	163 0.9×	117 1.3×	61 0.8×	54 0.8×	31 0.8×	17	336
Rajarshi Roy India	12	214 1.2×	121 1.3×	60 0.8×	79 1.2×	41 1.0×	31	402
Michael H. L. Wong United Kingdom	7	197 1.1×	85 0.9×	79 1.0×	49 0.7×	47 1.1×	7	478
Saad Raza Pakistan	14	317 1.7×	152 1.7×	102 1.3×	40 0.6×	55 1.3×	33	546
Yan Quan Lee Singapore	6	202 1.1×	118 1.3×	57 0.7×	52 0.8×	50 1.2×	11	569
Abdulrahim A. Alzain Sudan	13	218 1.2×	139 1.5×	119 1.5×	65 1.0×	21 0.5×	66	431
Pritika Ramharack South Africa	13	224 1.2×	123 1.4×	62 0.8×	149 2.2×	27 0.7×	39	537

Countries citing papers authored by Mutaib M. Mashraqi

Since Specialization

Citations

This map shows the geographic impact of Mutaib M. Mashraqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mutaib M. Mashraqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mutaib M. Mashraqi more than expected).

Fields of papers citing papers by Mutaib M. Mashraqi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mutaib M. Mashraqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mutaib M. Mashraqi. The network helps show where Mutaib M. Mashraqi may publish in the future.

Co-authorship network of co-authors of Mutaib M. Mashraqi

This figure shows the co-authorship network connecting the top 25 collaborators of Mutaib M. Mashraqi. A scholar is included among the top collaborators of Mutaib M. Mashraqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mutaib M. Mashraqi. Mutaib M. Mashraqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qasim, Muhammad, Fatima Noor, Muhammad Shahid, et al.. (2024). Potential Target Metabolites From Gut Microbiota Against Hepatocellular Carcinoma: A Network Pharmacology and Molecular Docking Study. International Journal of Microbiology. 2024(1). 4286228–4286228. 1 indexed citations

Mashraqi, Mutaib M., et al.. (2024). Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor. Pharmaceuticals. 17(2). 208–208. 4 indexed citations

Mashraqi, Mutaib M., et al.. (2023). Molecular Mimicry Mapping in Streptococcus pneumoniae: Cues for Autoimmune Disorders and Implications for Immune Defense Activation. Pathogens. 12(7). 857–857. 3 indexed citations

Hakami, Mohammed Ageeli, et al.. (2023). Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study. Medical Oncology. 40(8). 218–218. 6 indexed citations

Mashraqi, Mutaib M., et al.. (2023). Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. 42(7). 3507–3519. 1 indexed citations

Mashraqi, Mutaib M., et al.. (2023). Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. 42(1). 11–21. 1 indexed citations

Alshamrani, Saleh, Mutaib M. Mashraqi, Ahmad Alzamami, et al.. (2023). Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach. Microorganisms. 11(9). 2300–2300. 1 indexed citations

Dhawan, Manish, Ali A. Rabaan, Souad A. Almuthree, et al.. (2023). Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines. Vaccines. 11(1). 101–101. 29 indexed citations

Ahmed, Naveed, Ali A. Rabaan, Ameen S. S. Alwashmi, et al.. (2023). Immunoinformatic Execution and Design of an Anti-Epstein–Barr Virus Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses. Microorganisms. 11(10). 2448–2448. 7 indexed citations

10.

Rabaan, Ali A., Saad Alhumaid, Hawra Albayat, et al.. (2022). Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. Molecules. 27(16). 5335–5335. 16 indexed citations

11.

Mashraqi, Mutaib M., et al.. (2022). Prediction Model of Adverse Effects on Liver Functions of COVID-19 ICU Patients. Journal of Healthcare Engineering. 2022. 1–11. 4 indexed citations

12.

Khan, Kanwal, Zarrin Basharat, Khurshid Jalal, et al.. (2022). Identification of Therapeutic Targets in an Emerging Gastrointestinal Pathogen Campylobacter ureolyticus and Possible Intervention through Natural Products. Antibiotics. 11(5). 680–680. 6 indexed citations

13.

Alturki, Norah A., Mutaib M. Mashraqi, Khurshid Jalal, et al.. (2022). Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum. Cancers. 14(24). 6260–6260. 11 indexed citations

14.

Alturki, Norah A., Mutaib M. Mashraqi, Ahmad Alzamami, et al.. (2022). In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2. Molecules. 27(14). 4391–4391. 54 indexed citations

15.

Alzamami, Ahmad, Norah A. Alturki, Youssef Saeed Alghamdi, et al.. (2022). Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study. Medicina. 58(4). 515–515. 30 indexed citations

16.

Fatimawali, Fatimawali, Saad Alhumaid, Hawra Albayat, et al.. (2022). Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2. Vaccines. 10(10). 1734–1734. 3 indexed citations

17.

Mashraqi, Mutaib M., Qamre Alam, Saleh Alshamrani, et al.. (2021). Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs. Molecules. 26(3). 582–582. 12 indexed citations

18.

Alghamdi, Youssef Saeed, et al.. (2021). Effect of Ducrosia flabellifolia and Savignya parviflora Extracts on Inhibition of Human Colon and Prostate Cancer Cell Lines. Current Issues in Molecular Biology. 43(3). 1518–1528. 1 indexed citations

19.

Haque, Asma, Youssef Saeed Alghamdi, Mutaib M. Mashraqi, et al.. (2021). Development of a Candidate Multi-Epitope Subunit Vaccine against Klebsiella aerogenes: Subtractive Proteomics and Immuno-Informatics Approach. Vaccines. 9(11). 1373–1373. 22 indexed citations

20.

Rahaman, Abdul, Abdulraheem Ali Almalki, Misbahuddin M. Rafeeq, et al.. (2021). Identification of Potent Natural Resource Small Molecule Inhibitor to Control Vibrio cholera by Targeting Its Outer Membrane Protein U: An In Silico Approach. Molecules. 26(21). 6517–6517. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact